Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease

Background: Reduction of serum LDL-cholesterol by statins was shown to improve clinical outcomes in patients with coronary heart disease (CHD). Although intensive statin therapy significantly reduced cardiovascular risks, atherosclerotic cardiovascular events have not been completely prevented. Ther...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Atheroscler Thromb
Autores principales: Yamashita, Shizuya, Masuda, Daisaku, Ohama, Tohru, Arai, Hidenori, Bujo, Hideaki, Kagimura, Tatsuo, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji
Formato: Artigo
Lenguaje:Inglês
Publicado: Japan Atherosclerosis Society 2016
Materias:
Study Profile
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399286/
https://ncbi.nlm.nih.gov/pubmed/26803913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.32813
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares